Ontario grants broader access to Spinraza (nusinersen) for patients living with spinal muscular atrophy

13 June 2019 - Ontario joins Saskatchewan and Quebec to give patients with spinal muscular atrophy broader access to Spinraza. ...

Read more →

Ontario may lift ban preventing major pharmacies from selling private-label generic drugs

21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...

Read more →

Why Ontario parents could soon be paying more for prescription drugs

22 March 2019 - Some Ontario parents will be paying more for their kids’ medicine starting next month. Young adults ...

Read more →

Details of Doug Ford government’s health care overhaul, including new super agency, coming Tuesday

26 February 2019 - The Ontario government will announce its long-rumoured overhaul of the province’s health care system on Tuesday, ...

Read more →

Ontario becomes first province to provide public funding of Tresiba for adults with diabetes mellitus

21 September 2018 - Manitoba to reimburse Tresiba following Ontario listing. ...

Read more →

Ontario NDP promise take-home cancer drug coverage ahead of election

30 April 2018 - NDP Leader Andrea Horwath is promising universal access to take-home cancer drugs if her party wins ...

Read more →

Young Canadians feeling the pinch of sky-high prescription drug prices

26 March 2018 - Use of Ontario’s public drug program has increased three fold since 2000, which suggests that young ...

Read more →

Ontario family of toddler with rare disorder seeks funding for expensive drug

27 February 2018 - A family in Windsor, Ontario says they are being forced to choose between spending a fortune ...

Read more →

Ontario has added Erelzi (etanercept) to public drug plan for the treatment of multiple inflammatory diseases

9 January 2018 - Erelzi has been added to public drug plan based on specific criteria in Ontario for the treatment ...

Read more →

Novartis heart failure treatment Entresto (sacubitril/valsartan) now available to patients in Ontario through the public provincial drug plan

9 May 2017 - Entresto has been shown to reduce the risk of cardiovascular death and hospitalization in heart failure ...

Read more →

Provincial drug plans, including Ontario and BC, make Entyvio (vedolizumab) available to treat inflammatory bowel disease

9 May 2017 - Gut-selective treatment now funded publicly for Canadians with ulcerative colitis and Crohn's disease. ...

Read more →

Ontario cancer patient 'in limbo' over chemotherapy drug shortage

7 March 2017 - A cancer patient who was told last week that she may not receive her much-needed chemotherapy ...

Read more →

Ontario plans new treatment for opioid addiction

12 October 2016 - Ontario plans to treat patients addicted to opioids with a safer but more expensive pharmaceutical therapy ...

Read more →